ENTITY

Cosmo Pharmaceuticals Sa (COPN SW)

2
Analysis
Health CareLuxembourg
Cosmo Pharmaceuticals SA develops and manufactures therapies for gastrointestinal diseases. The Company's proprietary technology delays the delivery of the active drug mainly into the lumen of the colon. Cosmo develops treatments for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and for colon infections.
more
Company Event24 Jul 2024 20:00 • Latest
Company Event20 Mar 2024 22:00 • Upcoming
Add To Calendar
Company Event20 Mar 2024 18:00
Company Event26 Jul 2023 20:00
Company Event23 Mar 2023 21:00
x